Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Digestive and Liver Disease

Volumn 43, Issue 4, 2011, Pages 309-313

  Stanich, Peter P ^a   Björnsson, Einar ^a,b   Gossard, Andrea A ^a   Enders, Felicity ^a   Jorgensen, Roberta ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Alkaline phosphatase; Primary sclerosing cholangitis; Ursodeoxycholic acid

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; BILIARY TRACT BIOPSY; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DEATH; DRUG MEGADOSE; ENTERITIS; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RETROSPECTIVE STUDIES; SURVIVAL RATE; URSODEOXYCHOLIC ACID;

EID: 79952194307     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.12.008     Document Type: Article

References (17)

1. Thorpe M.E.C., Scheuer P.J., Sherock S. Primary sclerosing cholangitis, the biliary tree and ulcerative colitis. Gut 1967, 8:435-448.
2. Bambha K., Kim W.R., Talwalkar J., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125:1364-1369.
3. Graziadei I.W., Wiesner R.H., Marotta P.J., et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999, 30:1121-1127.
4. Kim W.R., Therneau T.M., Wiesner R.H., et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clinic Proc 2000, 75:688-694.
5. Poupon R.E., Bonnand A.M., Chrétien Y., et al. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology 1999, 29:1668-1671.
6. Pares A., Caballeria L., Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006, 130:715-720.
7. Kuiper E.M., Hansen B.E., de Vries R.A., et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 2009, 136:1281-1287.
8. Lindor K.D. Ursodiol for primary sclerosing cholangitis Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 1997, 336:691-695.
9. Olsson R., Boberg K.M., de Muckadell O.S., et al. High-dose ursodeoxycholic acid in primary sclerosing. Cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005, 129:1464-1472.
10. Lindor K.D., Kowdley K.V., Luketic V.A., et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009, 50:808-814.
11. Wiesner R.H., LaRusso N.F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980, 79:200-206.
12. Olsson R., Broomé U., Danielsson A., et al. Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features. Hepatogastroenterology 1999, 46:136-141.
13. Balasubramaniam K., Wiesner R.H., LaRusso N.F. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 1990, 98:1567-1571.
14. Ludwig J., Dickson E.R., McDonald G.S.A. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A: Pathol Anat Histol 1978, 379:103-112.
15. Björnsson E., Lindqvist-Ottosson J., Asztely M., et al. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol 2004, 99:502-508.
16. Stiehl A., Rudolph G., Klöters-Plachky P., et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002, 36:151-156.
17. Stiehl A., Rudolph G., Sauer P., et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 1997 Mar, 26:560-566.